SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018481
Filing Date
2018-08-01
Accepted
2018-08-01 16:27:33
Documents
50
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnlo-10q_20180630.htm 10-Q 1601135
2 EX-31.1 mnlo-ex311_284.htm EX-31.1 15966
3 EX-31.2 mnlo-ex312_282.htm EX-31.2 17273
4 EX-32.1 mnlo-ex321_283.htm EX-32.1 13986
  Complete submission text file 0001564590-18-018481.txt   4946664

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnlo-20180630.xml EX-101.INS 1043425
6 XBRL TAXONOMY EXTENSION SCHEMA mnlo-20180630.xsd EX-101.SCH 29715
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnlo-20180630_cal.xml EX-101.CAL 31655
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnlo-20180630_def.xml EX-101.DEF 99422
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnlo-20180630_lab.xml EX-101.LAB 242562
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnlo-20180630_pre.xml EX-101.PRE 180987
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 18985158
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1